Atorvastatin Prevents Cognitive Deficits Induced by Intracerebroventricular Amyloid-β Administration in Mice: Involvement of Glutamatergic and Antioxidant Systems.

MLA

Martins, Wagner, et al. “Atorvastatin Prevents Cognitive Deficits Induced by Intracerebroventricular Amyloid-β Administration in Mice: Involvement of Glutamatergic and Antioxidant Systems.” Neurotoxicity Research, vol. 28, no. 1, July 2015, pp. 32–42. EBSCOhost, https://doi.org/10.1007/s12640-015-9527-y.

APA

Martins, W., Santos, V., Santos, A., Vandresen-Filho, S., Dal-Cim, T., Oliveira, K., Mendes-de-Aguiar, C., Farina, M., Prediger, R., Viola, G., & Tasca, C. (2015). Atorvastatin Prevents Cognitive Deficits Induced by Intracerebroventricular Amyloid-β Administration in Mice: Involvement of Glutamatergic and Antioxidant Systems. Neurotoxicity Research, 28(1), 32–42. https://doi.org/10.1007/s12640-015-9527-y

Chicago

Martins, Wagner, Vanessa Santos, Alessandra Santos, Samuel Vandresen-Filho, Tharine Dal-Cim, Karen Oliveira, Claudia Mendes-de-Aguiar, et al. 2015. “Atorvastatin Prevents Cognitive Deficits Induced by Intracerebroventricular Amyloid-β Administration in Mice: Involvement of Glutamatergic and Antioxidant Systems.” Neurotoxicity Research 28 (1): 32–42. doi:10.1007/s12640-015-9527-y.